Related references
Note: Only part of the references are listed.Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options
Jesus Gonzalez Bosquet et al.
PLOS ONE (2021)
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1
Otto Kauko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
The mutational landscape of normal human endometrial epithelium
Luiza Moore et al.
NATURE (2020)
The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis
Sarah E. Taylor et al.
CANCER RESEARCH (2019)
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Michiel Remmerie et al.
FRONTIERS IN ONCOLOGY (2019)
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma
Frederik Holst et al.
CLINICAL CANCER RESEARCH (2019)
Clinical actionability of molecular targets in endometrial cancer
Mary Ellen Urick et al.
NATURE REVIEWS CANCER (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CIP2A is overexpressed in human endometrioid adenocarcinoma and regulates cell proliferation, invasion and apoptosis
Ning Yu et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back
Jukka Westermarck
FEBS JOURNAL (2018)
Molecular Genetics of Endometrial Carcinoma
Daphne W. Bell et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer
Fatemeh Mazloumi Gavgani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation
Thomas Karlsson et al.
ONCOTARGET (2017)
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer
Siv Mjos et al.
SCIENTIFIC REPORTS (2017)
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
Jaya Sangodkar et al.
FEBS JOURNAL (2016)
Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers
Anchit Khanna et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth
Dorien Haesen et al.
CANCER RESEARCH (2016)
Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance
Catherine A. Cremona et al.
SEMINARS IN CANCER BIOLOGY (2016)
PIK3CA Mutations are Common in Many Tumor Types and are Often Associated With Other Driver Mutations
Matthew D. Stachler et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)
Orchestrating high-throughput genomic analysis with Bioconductor
Wolfgang Huber et al.
NATURE METHODS (2015)
Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data
Jesus Gonzalez Bosquet et al.
CANCER RESEARCH (2014)
The Emerging Genomic Landscape of Endometrial Cancer
Matthieu Le Gallo et al.
CLINICAL CHEMISTRY (2014)
GSK-3 as potential target for therapeutic irvention in cancer
James A. McCubrey et al.
ONCOTARGET (2014)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Elisabetta Kuhn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Ets1 and Elk1 transcription factors regulate Cancerous Inhibitor of Protein phosphatase 2A expression in cervical and endometrial carcinoma cells
Rajash Pallai et al.
TRANSCRIPTION-AUSTIN (2012)
A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
Meghan L. Rudd et al.
CLINICAL CANCER RESEARCH (2011)
Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer
Paulette Mhawech-Fauceglia et al.
HISTOPATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
Lydia W. T. Cheung et al.
CANCER DISCOVERY (2011)
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H. B. Salvesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Circular binary segmentation for the analysis of array-based DNA copy number data
AB Olshen et al.
BIOSTATISTICS (2004)
Share Paper
